Garba Abdul

Garba Abdul is the director of vaccines and government relations at the Clinton Health Access Initiative in Nigeria. In this role, he is spearheading the broader vaccine drive and the effort to establish a “polio legacy” for the Nigerian health care system. Abdul has decades of experience working on public health in Nigeria. He was the lead in a Nigerian policy shift from an oral polio vaccine to inactivated polio by 2016. He has also succeeded in convincing the Nigerian government to introduce new vaccines with high potential impact, including penta vaccine, pneumococcal vaccine, and inactivated polio vaccine. He is an Aspen Institute New Voices fellow.